Skip to main content

Medications for Hodgkin's Lymphoma

Other names: Cancer, Hodgkin's Lymphoma; Hodgkin Disease; Hodgkin Lymphoma; Hodgkin's Disease; Lymphoma, Hodgkin's

Hodgkin lymphoma is a one of the cancers of the lymphatic system, which is part of the immune system. Hodgkin lymphoma can be distinguished from other lymphomas as Hodgkin lymphoma has specific large cells called Reed-Sternberg cells. 
Common symptoms of Hodgkin lymphoma are swollen lymph nodes (in the neck, under the arm, or the groin area), fever, night sweats and unintentional weight loss.
There are several different subtypes of Hodgkin lymphoma which behave differently and require different types of treatment.

Drugs used to treat Hodgkin's Lymphoma

The following list of medications are in some way related to or used in the treatment of this condition.

Filter
Drug name Rating Reviews Activity ? Rx/OTC Pregnancy CSA Alcohol
bleomycin Rate Add review
Rx D N
Generic name:
bleomycin systemic
Drug class:
antibiotics/antineoplastics
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
dacarbazine Rate Add review
Rx C N
Generic name:
dacarbazine systemic
Drug class:
alkylating agents
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
vinblastine Rate Add review
Rx D N
Generic name:
vinblastine systemic
Drug class:
mitotic inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
doxorubicin Rate Add review
Rx D N
Generic name:
doxorubicin systemic
Drug class:
antibiotics/antineoplastics
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
etoposide Rate Add review
Rx D N
Generic name:
etoposide systemic
Brand names:
Etopophos, Toposar
Drug class:
mitotic inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
nivolumab 10 1 review for nivolumab to treat Hodgkin's Lymphoma
Rx N
Generic name:
nivolumab systemic
Brand name:
Opdivo
Drug class:
anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Opdivo Rate Add review
Rx N
Generic name:
nivolumab systemic
Drug class:
anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Keytruda 10 1 review for Keytruda to treat Hodgkin's Lymphoma
Rx D N
Generic name:
pembrolizumab systemic
Drug class:
anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Adcetris Rate Add review
Rx D N X
Generic name:
brentuximab systemic
Drug class:
CD30 monoclonal antibodies
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
pembrolizumab 10 1 review for pembrolizumab to treat Hodgkin's Lymphoma
Rx D N
Generic name:
pembrolizumab systemic
Brand name:
Keytruda
Drug class:
anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Matulane Rate Add review
Rx D N X
Generic name:
procarbazine systemic
Drug class:
miscellaneous antineoplastics
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Etopophos Rate Add review
Rx D N
Generic name:
etoposide systemic
Drug class:
mitotic inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
brentuximab Rate Add review
Rx D N X
Generic name:
brentuximab systemic
Brand name:
Adcetris
Drug class:
CD30 monoclonal antibodies
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
cyclophosphamide Rate Add review
Rx D N
Generic name:
cyclophosphamide systemic
Drug class:
alkylating agents
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
vincristine Rate Add review
Rx D N
Generic name:
vincristine systemic
Drug class:
mitotic inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Leukeran Rate Add review
Rx D N
Generic name:
chlorambucil systemic
Drug class:
alkylating agents
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
methotrexate Off-label Rate Add review
Rx X N X
Generic name:
methotrexate systemic
Drug class:
antimetabolites, antirheumatics, antipsoriatics, other immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Off-label:
Yes
procarbazine Rate Add review
Rx D N X
Generic name:
procarbazine systemic
Brand name:
Matulane
Drug class:
miscellaneous antineoplastics
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Toposar Rate Add review
Rx D N
Generic name:
etoposide systemic
Drug class:
mitotic inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
CeeNU Rate Add review
Rx D N
Generic name:
lomustine systemic
Drug class:
alkylating agents
For consumers:
dosage, interactions, side effects
chlorambucil Rate Add review
Rx D N
Generic name:
chlorambucil systemic
Brand name:
Leukeran
Drug class:
alkylating agents
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
carmustine Rate Add review
Rx D N
Generic name:
carmustine systemic
Brand names:
Gliadel, BiCNU
Drug class:
alkylating agents
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Gliadel Rate Add review
Rx D N
Generic name:
carmustine systemic
Drug class:
alkylating agents
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
BiCNU Rate Add review
Rx D N
Generic name:
carmustine systemic
Drug class:
alkylating agents
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
lomustine Rate Add review
Rx D N
Generic name:
lomustine systemic
Brand names:
CeeNU, Gleostine
Drug class:
alkylating agents
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph

Frequently asked questions

View more FAQ

Learn more about Hodgkin's Lymphoma

Care guides

Symptoms and treatments

Legend

Rating For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity Activity is based on recent site visitor activity relative to other medications in the list.
Rx Prescription only.
OTC Over-the-counter.
Rx/OTC Prescription or Over-the-counter.
Off-label This medication may not be approved by the FDA for the treatment of this condition.
EUA An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.
Expanded Access Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.
Pregnancy Category
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act (CSA) Schedule
M The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.
U CSA Schedule is unknown.
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.